Introduction {#sec1-1}
============

Glaucoma is an optic neuropathy in which the optic nerve is damaged with typical loss of nerve fibers and increasing cupping of the optic disc, leading to progressive, irreversible loss of vision \[**[@R1]**,**[@R2]**\]. A leading cause of all blindness worldwide, secondary to cataracts, glaucoma is the main cause of irreversible vision loss \[**[@R3]**\]. It is estimated that more than 60 million people had glaucoma in 2010, 8.4 million of whom are bilaterally blind as a result of this disease \[**[@R4]**\]. In general, glaucoma might be classified in three major categories: primary open angle glaucoma (POAG), primary congenital glaucoma (PCG) and primary angle-closure glaucoma (PACG) \[**[@R5]**\].

Glaucoma is a multifactorial disease involving both environmental and genetic factors \[**[@R6]**,**[@R7]**\]. During the past decade, molecular genetic studies of glaucoma have yielded some success. The importance of genetic factors in the etiology of glaucoma is supported by genome-wide association studies (GWASs) \[**[@R8]**\]. Recently, several candidate novel loci have been identified in a GWAS for POAG (e.g., ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (e.g., EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A) \[**[@R8]**,**[@R9]**\]. Furthermore, several epidemiological studies have reported a link between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and glaucoma \[**[@R10]**,**[@R11]**\].

The MTHFR gene is located on chromosome 1p36.3 \[**[@R12]**,**[@R13]**\]. It is an important regulatory enzyme in the folate related one carbon metabolism, which is responsible for catalyzing 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate \[**[@R14]**,**[@R15]**\]. In addition, MTHFR plays an important role by directing folate metabolites through the DNA methylation pathways \[**[@R12]**\]. An increased level of plasma homocysteine (Hcy) has been observed in patients with glaucoma \[**[@R16]**\]. The MTHFR gene is encoded by 11 exons and includes several SNP, some of which have functional relevance and result in high Hcy level. Many studies have shown an increased risk of glaucoma in patients with MTHFR C677T and A1298C polymorphism. However, results from these studies were inconsistent or inconclusive. It was suggested that this inconsistency might be related to the single studies with low statistical power, publication biases, and ethnicity differences. Thus, we have performed the current systematic review and meta-analysis to collecting and summarizing the evidence on the association of MTHFR C677T and A1298C polymorphisms with the risk of glaucoma.

Materials and Methods {#sec1-2}
=====================

**Study Identification and Selection**

We have performed a comprehensive literature search using PubMed, Web of Science, Google Scholar, Cochrane Library, Embase, and Chinese Biomedical Literature database (CBM) databases to identify studies that evaluated the association between MTHFR C677T polymorphism and the risk of glaucoma up to October 2018, with the following keywords: "Methylenetetrahydrofolate reductase", "MTHFR", "MTHFR C677T", or "MTHFR A1298C" and "polymorphism", "mutation", or "variant" and "glaucoma" and "primary open-angle glaucoma" or "POAG" and "pseudoexfoliation glaucoma" or "PXFG", "pseudoexfoliation syndrome with glaucoma" or "PEXG" and "normal-tension glaucoma" or "NTG" and "primary angle-closure glaucoma" or "PACG" and "primary angle-closure glaucoma" or "PACG", "high-tension glaucoma" or "HTG", and "juvenile-onset open-angle glaucoma" or "JOAG". We have retrieved any article matching the keywords and we evaluated it by reading the title and abstract. In addition, we have screened the references lists of the retrieved articles for original papers.

**Inclusion and Exclusion Criteria**

The following criteria were used for the study selection: 1) a case-control study evaluating the association of MTHFR C677T and A1298C polymorphisms with the risk of glaucoma and its types; 2) case-control or cohort studies; 3) sufficient data for estimating an odds ratio (OR) with 95% confidence interval (CI); 4) no overlapping data. In addition, if studies had the same or overlapping data, we have included only the largest study in the final analysis. The major excluding criteria for studies were the following: (1) not glaucoma research, (2) reviews, letters or case reports, (3) duplicate of previous publication, and (4) and those articles without definite information of genotypes.

**Data Extraction**

We have extracted information carefully from all the eligible studies independently by two investigators based on the above listed inclusion criteria. The following data were collected from each study: the first author's name, the year of publication, ethnicity, country of origin, glaucoma type, genotyping method, source of control groups (population-based or hospital-based controls), total number of cases and controls, the frequencies of genotypes, minor allele frequencies (MAFs), and Hardy-Weinberg equilibrium (HWE) test in control subjects. Allele frequencies were calculated from the corresponding genotype distributions using an online website. Finally, the extracted data in terms of accuracy and any discrepancy between these two authors was resolved by reaching a consensus through discussion or the involvement of a third author who made the final decision through discussions.

**Statistical Analysis**

Pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated to assess the association of MTHFR C677T and A1298C polymorphisms with the risk of glaucoma. The significance of the pooled OR was determined by the Z-test. The pooled ORs were performed under five genetic models, i.e., allele (B vs. A), homozygote (BB vs. AA), heterozygote (BA vs. AA), dominant (BB+BA vs. AA), and recessive (BB vs. BA+AA), which a "A" denotes a major allele; "B" denotes a minor allele. Heterogeneity (between-study inconsistency) was assessed by the Cochran Χ2-based Q test (Heterogeneity was considered statistically significant if P\<0.10) and the I2 statistics. An I2 value of 0% represents no heterogeneity, with values of 25%, 50%, 75%, or more represent low, moderate, high, and ex¬treme heterogeneity, respectively. A fixed effect model (Mantel-Haenszel method) was used to calculate pooled OR when there was no heterogeneity among the studies. Otherwise, the fixed-effects model (Mantel-Haenszel approach) was used. We have calculated the Hardy-Weinberg equilibriums (HWEs) with goodness-of-fit tests (i.e., chi-square or Fisher's exact tests). In addition, one-way sensitivity analyses were carried out by consecutively omitting one study at a time to assess power of the meta-analysis \[**[@R15]**\]. In addition, sensitivity analysis was also performed, excluding studies whose allele frequencies in controls exhibited a significant deviation from the Hardy--Weinberg equilibrium (HWE), given that the deviation may denote bias. Deviation of HWE may reflect methodological problems such as genotyping errors, population stratification or selection bias. Visual inspection of the asymmetry of funnel plots was carried out to assess potential publication bias. Begg's funnel plot, a scatter plot of effect against a measure of study size was used as a visual aid to detect bias or systematic heterogeneity. Publication bias was assessed by Egger's test (p\<0.05 was considered statistically significant). If publication bias existed, the Duval and Tweedie non-parametric "trim and fill" method was used to adjust for it. A meta-regression analysis was carried out to identify the major sources of between-studies variation in the results, using the log of the ORs from each study as dependent variables, and ethnicity and source of controls as the possible sources of heterogeneity. All the statistical calculations were performed using Comprehensive Meta-Analysis (CMA) software version 2.0 (Biostat, USA). Two-sided P-values \< 0.05 were considered statistically significant.

Results {#sec1-3}
=======

**Study Selection and Characteristics**

A flow diagram schematizing the inclusion and exclusion process of identified articles with the inclusion criteria is presented in **[Fig. 1](#F1){ref-type="fig"}**

![Flow chart of literature search and study selection](RomJOphthalmol-63-107-g001){#F1}

After a comprehensive search, a total of 342 articles were identified. Of these studies, the first screening excluded 216 as duplicates or not relevant, leaving 126 for further selection. Among the remaining studies, 84 articles were excluded because they were review articles, letters to editors, previous meta-analyses, not relevant to MTHFR C677T and A1298C, not case-control studies, evaluated other diseases instead of glaucoma, case reports, and other polymorphisms of MTHFR gene. Finally, a total of 42 case-control studies including 33 studies (in 19 publications) with 3,504 cases and 2,525 controls for MTHFR C677T \[**[@R9]**--**[@R11]**,**[@R17]**--**[@R31]**\] and nine studies (in six publications) with 1,073 cases and 775 controls for A1298C \[**[@R11]**,**[@R19]**--**[@R21]**,**[@R23]**,**[@R29]**\] were selected. The main characteristics of studies included in the current meta-analysis are presented in **[Tables 1](#T1){ref-type="table"}** and **[2](#T2){ref-type="table"}**.

###### 

Characteristics of the studies included in the MTHFR C677T polymorphism meta-analysis

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------ ------ --------- ----- ---------------------- ----------- ----- ------- --------- ----- ----------- ----- --------- --------- ----- ------- -------
  First author                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Country (Ethnicity)     Type   Case   Control   SOC   Genotyping Technique                     Cases                                     Control                   MAFs    HWE
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Genotypes                 Alleles         Genotypes                   Alleles                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       CC          TC    TT      C         T     CC          TC    TT        C         T             
  Bleich 2002                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Germany (Caucasian)     POAG   18     19        PB    RT--PCR                5           11    2       21        15    13          5     1         31        7     0.184   0.587
  Jünemann 2005                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Germany (Caucasian)     POAG   76     71        HB    RT--PCR                32          37    7       101       51    45          24    2         114       28    0.197   0.568
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PEXG   71                                            36          29    6       101       41                                                        
  Mossbock 2006                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Austria (Caucasian)     POAG   204    211       HB    PCR-RFLP               119         71    14      309       99    105         86    20        296       126   0.298   0.695
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PXFG   138                                           72          50    16      194       82                                                        
  Mabuchi 2006                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Japan (Asian)           POAG   133    106       HB    Sequencing             51          55    27      157       109   48          39    19        135       77    0.363   0.035
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NTG    131                                           54          58    19      166       96                                                        
  Fingert 2006                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            USA (Caucasian)         POAG   178    166       PB    PCR-RFLP               72          77    29      221       135   75          73    18        223       109   0.328   0.969
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PEXG   45                                            12          29    4       53        37                                                        
  Zetterberg 2007                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Estonia (Caucasian)     POAG   243    187       HB    Sequencing             126         97    20      349       137   89          75    23        253       121   0.323   0.252
  Fan 2008                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                USA (Caucasian)         PXFG   61     50        HB    TaqMan                 23          31    7       78        44    21          22    7         64        36    0.360   0.749
  Michael 2008                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Pakistan (Asian)        POAG   90     70        HB    PCR-RFLP               70          20    0       160       20    57          13    0         127       13    0.092   0.391
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PACG   60                                            48          8     4       104       16                                                        
  Michael 2009                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Pakistan (Asian)        POAG   173    143       HB    PCR-RFLP               123         49    1       295       51    101         41    1         243       43    0.150   0.143
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PACG   122                                           84          26    12      194       50                                                        
  Clement 2009                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Australia (Caucasian)   POAG   36     42        PB    RT--PCR                17          14    5       48        24    25          14    3         64        20    0.238   0.598
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PXFG   48                                            18          23    7       59        37                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NTG    34                                            21          11    2       53        15                                                        
  Woo 2009                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Korea (Asian)           NTG    78     100       HB    PCR-RFLP               25          34    19      84        72    31          50    19        112       88    0.440   0.883
  Fan 2010                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Hong Kong (Asian)       HTG    255    201       PB    Sequencing             11          87    154     110       400   6           60    135       72        330   0.820   0.829
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  NTG    100                                           5           30    64      40        160                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  JOAG   50                                            0           20    26      22        78                                                        
  Nilforoushan 2012                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Iran (Asian)            POAG   73     90        HB    Sequencing             39          28    6       106       40    53          33    4         139       41    0.227   0.688
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PXFG   85                                            46          31    8       123       47                                                        
  Shi 2013                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                China (Asian)           PACG   231    306       HB    TaqMan                 81          106   44      268       194   93          152   61        338       274   0.447   0.937
  Buentello 2013                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Mexico (Latinos)        POAG   118    100       HB    Sequencing             23          53    42      99        137   17          49    34        83        117   0.585   0.926
  Gupta 2014                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              India (Asian)           POAG   144    173       HB    PCR-RFLP               101         35    8       237       51    137         34    2         308       38    0.109   0.946
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PACG   87                                            73          14    0       160       14                                                        
  Zacharaki 2014                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Greece (Caucasian)      POAG   64     130       HB    TaqMan                 22          31    11      75        53    39          70    21        148       112   0.430   0.263
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PXFG   72                                            29          33    10      91        53                                                        
  Al-Shahrani 2015                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Saudi Arabia (Asian)    POAG   144    280       NR    PCR-RFLP               88          56    0       232       56    210         70    0         490       70    0.125   0.016
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  PACG   66                                            49          17    0       115       17                                                        
  Dixit 2015                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              India (Asian)           POAG   80     80        HB    PCR-RFLP               49          30    1       128       32    30          48    2         108       52    0.325   0.001
  *POAG = primary open angle glaucoma, PXFG = pseudoexfoliation glaucoma, PEXG = pseudoexfoliation syndrome with glaucoma, NTG = normal-tension glaucoma, PACG = primary angle-closure glaucoma, HTG = high-tension glaucoma, JOAG = juvenile-onset open-angle glaucoma, SOC = source of control, PCR--RFLP = Polymerase chain reaction-restriction fragment length polymorphism, RT--PCR = Real time-polymerase chain reaction, NR = Not report, PB = Population--based, HB = Hospital--based, MAFs = Minor Allele Frequency, HWE = Hardy--Weinberg equilibrium in control population*                                                                                                                                                                              
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------ ------ --------- ----- ---------------------- ----------- ----- ------- --------- ----- ----------- ----- --------- --------- ----- ------- -------

###### 

Characteristics of the studies included in the MTHFR A1298C polymorphism meta-analysis

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------- ------ ------ --------- ----- ---------------------- ----------- ----- ------- --------- ----- ----------- ---- --------- --------- ----- ------- --------
  First author                                                                                                                                                                                                                                                                                                                                                           Country (Ethnicity)   Type   Case   Control   SOC   Genotyping Technique                     Cases                                    Control                   MAFs    HWE
                                                                                                                                                                                                                                                                                                                                                                                                                                                    Genotypes                 Alleles         Genotypes                  Alleles                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                    AA          AC    CC      A         C     AA          AC   CC        A         C             
  Mabuchi 2006                                                                                                                                                                                                                                                                                                                                                           Japan(Asian)          POAG   133    106       HB    Sequencing             87          43    3       217       49    61          44   1         166       46    0.217   0.022
                                                                                                                                                                                                                                                                                                                                                                                               NTG    131                                           80          51    0       211       51                                                       
  Zetterberg 2007                                                                                                                                                                                                                                                                                                                                                        Estonia(Caucasian)    POAG   243    187       HB    Sequencing             119         97    27      335       151   88          87   12        263       111   0.296   0.117
  Fan 2008                                                                                                                                                                                                                                                                                                                                                               USA (Caucasian)       PXFG   57     50        HB    TaqMan                 26          20    11      72              22          19   9         63        37    0.370   0.191
  Micheal 2009                                                                                                                                                                                                                                                                                                                                                           Pakistan(Asian)       POAG   173    146       HB    PCR-RFLP               35          114   24      184       162   20          97   26        140       152   0.521   ≤0.001
                                                                                                                                                                                                                                                                                                                                                                                               PACG   122                                           34          76    12      144       100                                                      
  Woo 2009                                                                                                                                                                                                                                                                                                                                                               Korea(Asian)          NTG    78     156       HB    PCR-RFLP               57          19    2       133       23    75          22   3         172       28    0.140   0.387
  Zacharaki 2014                                                                                                                                                                                                                                                                                                                                                         Greece(Caucasian)     POAG   64     130       HB    TaqMan                 11          31    22      53        75    21          70   39        112       148   0.569   0.263
                                                                                                                                                                                                                                                                                                                                                                                               PXFG   72                                            10          33    29      53        91                                                       
  *POAG = primary open angle glaucoma, PXFG = pseudoexfoliation glaucoma, NTG = normal-tension glaucoma, PACG = primary angle-closure glaucoma, SOC = source of control, PCR--RFLP = Polymerase chain reaction-restriction fragment length polymorphism, HB = Hospital--based, MAFs = Minor Allele Frequency, HWE = Hardy--Weinberg equilibrium in control population*                                                                                                                                                                           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------- ------ ------ --------- ----- ---------------------- ----------- ----- ------- --------- ----- ----------- ---- --------- --------- ----- ------- --------

Among these studies, six types of glaucoma, including primary open angle glaucoma (POAG), pseudoexfoliation glaucoma (PXFG) or pseudoexfoliation syndrome with glaucoma (PEXG), normal-tension glaucoma (NTG), primary angle-closure glaucoma (PACG), high-tension glaucoma (HTG), and juvenile-onset open-angle glaucoma (JOAG) were involved. Among the selected studies, 23 case-control studies were conducted in the Asians, 18 studies were conducted in the Caucasians, and one study was conducted in the Latinos. Genotyping methods used in the studies include PCR-RFLP, Real-time PCR, TaqMan, and sequencing. The genotype frequencies in the control group for three publications did not fit well in the Hardy-Weinberg equilibrium (P\>0.05).

**Quantitative Synthesis**

**MTHFR C677T Polymorphism**

**[Table 3](#T3){ref-type="table"}** listed the main results of the meta-analysis of MTHFR C677T polymorphism and glaucoma risk. After the 33 case-control studies were pooled into meta-analysis, no evidence of a significant association between MTHFR C677T polymorphism and glaucoma risk was observed under all genetic models (T vs. C: OR = 1.120. 95% CI 0.994-1.262, P = 0.062, **[Fig. 2A](#F2){ref-type="fig"}**; TT vs. CC: OR = 1.081. 95% CI 0.899-1.299, P = 0.410; TC vs. CC: OR = 1.033. 95% CI 0.899-1.188, P = 0.646; TT+TC vs. CC: OR = 1.113. 95% CI 0.948-1.306, P = 0.193; TT vs. TC+CC: OR = 1.015. 95% CI 0.876-1.175, P = 0.845).

###### 

Summary risk estimates for association between MTHFR C677T polymorphism and glaucoma risk

  ------------------ --------------- --------------- --------------- -------- ------------ -------------- -------- ------- ------------------ ---------
  Subgroup           Genetic Model   Type of Model   Heterogeneity            Odds ratio                                   Publication Bias   
                                                     I2 (%)          PH       OR           95% CI         ZOR      POR     PBeggs             PEggers
  Overall            T vs. C         Random          56.96           ≤0.001   1.120        0.994-1.262    1.864    0.062   0.052              0.031
                     TT vs. CC       Fixed           26.28           0.095    1.081        0.899-1.299    0.824    0.410   0.010              0.008
                     TC vs. CC       Random          34.76           0.027    1.033        0.899-1.188    0.460    0.646   0.168              0.219
                     TT+TC vs. CC    Random          55.75           ≤0.001   1.113        0.948-1.306    1.303    0.193   0.752              0.470
                     TT vs. TC+CC    Fixed           31.31           0.054    1.015        0.876-1.175    0.195    0.845   0.022              0.005
  By Glaucoma Type                                                                                                                            
  POAG               T vs. C         Random          66.56           ≤0.001   1.199        0.983-1.462    1.791    0.073   0.373              0.152
                     TT vs. CC       Fixed           36.99           0.087    1.120        0.853-1.470    0.816    0.414   0.200              0.145
                     TC vs. CC       Random          59.03           0.002    1.127        0.887-1.431    0.977    0.329   0.322              0.384
                     TT+TC vs. CC    Random          64.72           ≤0.001   1.149        0.898-1.470    1.105    0.269   0.428              0.264
                     TT vs. TC+CC    Fixed           11.19           0.333    1.124        0.878-1.439    0.927    0.354   0.582              0.166
  PACG               T vs. C         Fixed           29.71           0.223    0.99         0.828-1.200    -0.033   0.974   0.806              0.501
                     TT vs. CC       Random          69.18           0.021    2.356        0.407-13.650   0.956    0.339   1.000              0.359
                     TC vs. CC       Fixed           0.00            0.946    0.820        0.636-1.056    -1.537   0.124   0.806              0.971
                     TT+TC vs. CC    Fixed           0.00            0.807    0.903        0.710-1.149    -0.828   0.408   1.000              0.458
                     TT vs. TC+CC    Random          68.98           0.022    2.594        0.457-14.733   1.076    0.282   1.000              0.363
  PXFG + PEXG        T vs. C         Fixed           39.66           0.127    1.151        0.965-1.372    1.563    0.118   0.133              0.080
                     TT vs. CC       Fixed           9.68            0.355    1.271        0.843-1.914    1.145    0.252   0.308              0.284
                     TC vs. CC       Fixed           45.22           0.090    1.101        0.859-1.411    0.761    0.447   0.734              0.320
                     TT+TC vs. CC    Random          52.93           0.047    1.295        0.908-1.847    1.426    0.154   0.734              0.372
                     TT vs. TC+CC    Fixed           0.00            0.591    1.208        0.820-1.780    0.956    0.339   0.734              0.249
  NTG                T vs. C         Random          74.92           0.008    1.179        0.742-1.871    0.697    0.486   1.000              0.744
                     TT vs. CC       Fixed           0.00            0.610    1.019        0.698-1.488    0.096    0.923   0.308              0.202
                     TC vs. CC       Fixed           0.00            0.771    0.923        0.567-1.502    -0.323   0.746   0.734              0.503
                     TT+TC vs. CC    Random          68.19           0.024    1.217        0.634-2.339    0.590    0.555   0.308              0.512
                     TT vs. TC+CC    Fixed           51.54           0.103    1.069        0.756-1.512    0.78     0.706   0.308              0.912
  By ethnicity                                                                                                                                
  Asian              T vs. C         Random          60.66           0.00     1.113        0.941-1.317    1.251    0.211   0.939              0.622
                     TT vs. CC       Fixed           31.93           0.113    1.105        0.842-1.450    0.723    0.470   0.198              0.149
                     TC vs. CC       Fixed           35.16           0.071    1.006        0.833-1.214    0.059    0.953   0.448              0.598
                     TT+TC vs. CC    Random          58.36           0.001    1.063        0.851-1.329    0.539    0.590   0.081              0.151
                     TT vs. TC+CC    Random          52.48           0.009    1.146        0.821-1.599    0.798    0.425   0.198              0.053
  Caucasian          T vs. C         Random          57.90           0.004    1.139        0.946-1.72     1.373    0.170   0.028              0.007
                     TT vs. CC       Fixed           35.06           0.102    1.088        0.829-1.428    0.607    0.544   0.044              0.022
                     TC vs. CC       Random          46.01           0.035    1.094        0.8858-1.394   0.723    0.470   0.017              0.010
                     TT+TC vs. CC    Random          60.39           0.003    1.195        0.914-1.562    1.300    0.194   0.032              0.010
                     TT vs. TC+CC    Fixed           1.848           0.428    1.087        0.837-1.412    0.626    0.531   0.246              0.077
  ------------------ --------------- --------------- --------------- -------- ------------ -------------- -------- ------- ------------------ ---------

![Forest plots for the association of MTHFR C677T and A1298C polymorphisms with risk of risk glaucoma. A: MTHFR C677T (allele model: T vs. C); B: MTHFR A1298C (heterozygote model: CA vs. AA)](RomJOphthalmol-63-107-g002){#F2}

In the subgroup analysis by glaucoma type, no significant associations with POAG, PACG, PXFG, and NTG subgroups were observed. Moreover, no significant association was found in a subgroup analysis by ethnicity among Asian and Caucasian populations (**[Table 3](#T3){ref-type="table"}**). The studies were further stratified based on genotyping technique, source of control subjects and HWE. In the PCR-RFLP group, significantly increased association between *MTHFR C677T* polymorphism and glaucoma risk were found in the recessive model (TT vs. TC+CC: OR = 1.438. 95% CI 1.056-1.958, P = 0.021). The population based subgroup analysis also revealed that the presence of the *MTHFR C677T*, which was related to a higher risk of glaucoma under the heterozygote model (TT vs. TC: OR = 1.350, 95% CI 1.012-1.802, P = 0.041). Subgroup analysis of studies in accordance with HWE showed that there was a significant association between *MTHFR C677T* polymorphism and the increased risk of glaucoma under the allele model (OR = 1.156, 95% CI 1.020-1.309, p = 0.023) (data not shown).

**MTHFR A1298C Polymorphism**

**[Table 4](#T4){ref-type="table"}** listed the main results of the meta-analysis of *MTHFR A1298C* polymorphism and glaucoma risk. When all the eligible studies were pooled into the meta-analysis of *MTHFR A1298C* polymorphism, significantly increased risk of glaucoma was observed in the heterozygote model (CA vs. AA: OR = 0.765, 95% CI 0.626-0.935, p = 0.009, **[Fig. 2B](#F2){ref-type="fig"}**). Table 4 also summarizes the results of the subgroup analyses by ethnicity and types of glaucoma. When stratified by ethnicity, a significant association between *MTHFR A1298C* polymorphism and increased risk of glaucoma was detected among Asians (C vs. A: OR = 0.826, 95% CI 0.692-0.987, p = 0.036; CC vs. AA: OR = 0.456, 95% CI 0.268-0.777, p = 0.004; and CA vs. AA: OR = 705, 95% CI 0.541-0.918, p = 0.010) and Caucasians (CC vs. CA+AA: OR = 1.443, 95% CI 1.019-2.044, p = 0.039). In addition, when stratifying by types of glaucoma, we found that *MTHFR A1298C* was significantly associated with POAG risk under heterozygote model (CA vs. AA: OR = 0.746, 95% CI 0.570-0.976, p= 0.033), but not with PXFG and NTG (**[Table 4](#T4){ref-type="table"}**). Moreover, subgroup analysis of studies in agreement with HWE showed that there was a significant association between *MTHFR A1298C* polymorphism and increased risk of glaucoma under the recessive model (OR = 1.440, 95% CI 1.023-2.026, p = 0.037) (data not shown).

###### 

Summary risk estimates for association between MTHFR A1298C polymorphism and glaucoma risk

  ----------------------- --------------- --------------- --------------- ------- ------------ ------------- -------- ------- ------------------ ---------
  Subgroup                Genetic Model   Type of Model   Heterogeneity           Odds ratio                                  Publication Bias   
                                                          I2 (%)          PH      OR           95% CI        ZOR      POR     PBeggs             PEggers
  Overall                 C vs. A         Fixed           42.53           0.084   0.943        0.826-1.075   -0.880   0.379   0.602              0.257
                          CC vs. AA       Fixed           44.50           0.072   0.878        0.627-1.231   -0.753   0.425   0.602              0.909
                          CA vs. AA       Fixed           0.00            0.753   0.765        0.626-0.935   -2.610   0.009   0.602              0.666
                          CC+CA vs. AA    Fixed           26.84           0.205   0.873        0.721-1.058   -1.381   0.167   0.602              0.620
                          CC vs. CA+AA    Fixed           24.92           0.222   1.083        0.824-1.422   0.571    0.568   0.754              0.924
  By Type                                                                                                                                        
  POAG                    C vs. A         Fixed           0.00            0.507   0.939        0.787-1.120   -0.700   0.484   0.734              0.857
                          CC vs. AA       Fixed           38.10           0.183   1.027        0.655-1.611   0.115    0.908   1.000              0.767
                          CA vs. AA       Fixed           0.00            0.861   0.746        0.570-0.976   -2.138   0.033   1.000              0.763
                          CC+CA vs. AA    Fixed           0.00            0.837   0.832        0.643-1.077   -1.394   0.163   1.000              0.673
                          CC vs. CA+AA    Fixed           26.28           0.254   1.153        0.798-1.666   0.757    0.449   0.308              0.539
  PXFG                    C vs. A         Fixed           0.00            0.449   1.179        0.844-1.646   0.966    0.334   NA                 NA
                          CC vs. AA       Fixed           0.00            0.558   1.313        0.665-2.591   0.785    0.432   NA                 NA
                          CA vs. AA       Fixed           0.00            0.864   0.938        0.513-1.715   -0.217   0.836   NA                 NA
                          CC+CA vs. AA    Fixed           0.00            0.670   1.050        0.601-1.833   0.170    0.865   NA                 NA
                          CC vs. CA+AA    Fixed           0.00            0.530   1.422        0.852-2.374   1.346    0.178   NA                 NA
  NTG                     C vs. A         Fixed           70.83           0.064   1.204        0.608-2.382   0.532    0.595   NA                 NA
                          CC vs. AA       Fixed           0.00            0.512   0.650        0.133-3.171   -0.533   0.594   NA                 NA
                          CA vs. AA       Fixed           0.00            0.477   0.926        0.607-1.413   -0.356   0.722   NA                 NA
                          CC+CA vs. AA    Fixed           71.59           0.061   1.178        0.783-1.773   0.785    0.432   NA                 NA
                          CC vs. CA+AA    Fixed           0.00            0.391   0.910        0.188-4.402   -0.118   0.906   NA                 NA
  By Ethnicity                                                                                                                                   
  Asians                  C vs. A         Fixed           52.89           0.075   0.826        0.692-0.987   -2.099   0.036   0.220              0.115
                          CC vs. AA       Fixed           0.00            0.433   0.456        0.268-0.777   -2.888   0.004   0.806              0.473
                          CA vs. AA       Fixed           0.420           0.404   0.705        0.541-0.918   -2.592   0.010   1.000              0.750
                          CC+CA vs. AA    Random          59.70           0.042   0.829        0.554-1.241   -0.910   0.363   1.000              0.417
                          CC vs. CA+AA    Fixed           0.00            0.593   0.686        0.442-1.063   -1.686   0.092   0.806              0.576
  Caucasian               C vs. A         Fixed           0.00            0.852   1.106        0.909-1.345   1.004    0.316   0.734              0.997
                          CC vs. AA       Fixed           0.00            0.824   1.362        0.881-2.106   1.390    0.165   0.308              0.196
                          CA vs. AA       Fixed           0.00            0.985   0.856        0.628-1.167   -0.984   0.325   0.089              0.242
                          CC+CA vs. AA    Fixed           0.00            0.956   0.959        0.715-1.286   -0.279   0.780   0.308              0.465
                          CC vs. CA+AA    Fixed           0.00            0.783   1.443        1.019-2.044   2.066    0.039   1.000              0.578
  *NA = Not Applicable*                                                                                                                          
  ----------------------- --------------- --------------- --------------- ------- ------------ ------------- -------- ------- ------------------ ---------

**Minor Allele Frequencies (MAFs)**

The minor allele frequencies (MAFs) of the MTHFR C677T and A1298C polymorphisms by ethnicity are presented in **[Tables 1](#T1){ref-type="table"}** and **[2](#T2){ref-type="table"}**. The allele and genotype distributions of MTHFR C677T and A1298C polymorphisms exhibited ethnic variations. The 677T allele frequencies in the Caucasian and Asians populations were 30.7% (18.4%-43.0%) and 22.75% (9.2%-36.3%), respectively. The 1298C allele frequencies in the Caucasian and Asians populations were 34.3% (11.7%-56.9%) and 17.85% (14.0%-21.7%), respectively. Therefore, the frequencies of the 677T and 1298C alleles in Asians were less than in Caucasians.

**Heterogeneity Test and Sensitivity Analyses**

There was a significant heterogeneity among these studies for *MTHFR C677T* polymorphism under allele model comparison (T vs. C: Ph = ≤ 0.001), homozygote model comparison (TT vs. CC: Ph = 0.005) and dominant model comparison (TT + CT vs. CC: Ph = 0.001). Then, we assessed the source of heterogeneity by meta-regression analysis. However, we found that ethnicity, glaucoma types, genotyping methods, source of controls and HWE did not contribute to substantial heterogeneity among the meta-analysis (**[Table 2](#T2){ref-type="table"}**). Sensitivity analyses were conducted to determine whether modification of the inclusion criteria of the current meta-analysis affected the findings. Although the sample size for cases and controls in all eligible studies ranged from 18 to 243, the pooled ORs were not qualitatively altered by omitting the study of small sample. Three studies (Mabuchi et al., Al-Shahrani et al., and Dixit et al.) were not in HWE; however, the overall association was unchanged after the exclusion of these studies, which indicated that the results from this meta-analysis were statistically robust. Moreover, the heterogeneity test showed that there was no significant between-study heterogeneity in terms of the *MTHFR A1298C* polymorphism in the overall comparisons and subgroup analyses (**[Table 3](#T3){ref-type="table"}**).

**Publication Bias**

We have used both Begg's funnel plot and Egger's test to access the small study effects of articles in literature. The shape of the fun¬nel plots did not reveal an obvious asymmetry. Then, the Egger's test was used to provide statistical evidence of funnel plot symmetry. Egger's test found evidence for the publication bias between MTHFR C677T polymorphism and glaucoma risk under the allele model (T vs. C: PBegg = 0.052, PEgger = 0.031, **[Fig. 3](#F3){ref-type="fig"}**), homozygote model (TT vs. CC: PBegg = 0.010, PEgger = 0.008) and the recessive model (TT vs. CT + CC: PBegg = 0.022, PEgger = 0.005). This finding might be a limitation for this meta-analysis because studies with null findings, especially those with small sample size, are less likely to be published. The Duval and Tweedie non-parametric "trim and fill" method was used to adjust for publication bias. Meta-analysis with and without "trim and fill" did not draw a different conclusion, indicating that our results were statistically robust. Moreover, no significant publication bias for *MTHFR A1298C* polymorphism was found by Egger's test in the overall or subgroup analyses.

![Begg's funnel plots (publication bias) for the association of MTHFR C677T polymorphism with risk of glaucoma under allele model (T vs. C)AA)](RomJOphthalmol-63-107-g003){#F3}

Discussion {#sec1-4}
==========

To the best of our knowledge, this is the first and most comprehensive meta-analysis assessing the associations of *MTHFR C677T* and *A1298C* polymorphisms with risk of different types of glaucoma. A total of 33 case-control studies in 19 publications (3,504 cases and 2,525 controls) and nine case-control studies in six publications (1,073 cases and 775 controls) have investigated the associations of *MTHFR C677T* and *A1298C* polymorphisms with glaucoma risk, respectively. Our meta-analysis showed that *MTHFR C677T* polymorphism was not associated with glaucoma risk. Similar results were observed in the subgroup analyses based on ethnicity and types of glaucoma (POAG, PACG, PEXG, and NTG). However, we have found that the *MTHFR A1298C* may be associated with an increased glaucoma risk overall and by ethnicity. Moreover, in a subgroup analysis of glaucoma types, *MTHFR A1298C* polymorphism was significantly associated with an increased risk of POAG, but not with PXFG and NTG subgroups.

Interestingly, stratified analysis according to genotyping technique revealed a significantly increased risk of glaucoma in participants with the C677T polymorphism in those studies involving PCR-RFLP under recessive genetic model (TT vs. TC+CC: OR = 1.438, 95% CI 1.056-1.958, P = 0.021). With the recent advent of sophisticated high-throughput genotyping technologies such as semi nested PCR, the TaqMan allelic discrimination test, or real-time PCR, we may witness a significant progress in the association studies in the future \[**[@R32]**\]. High sensitivity of real-time PCR makes the technique applicable to very small samples \[**[@R33]**\]. However, this trend is possible because studies involving Caucasians mainly utilized Real-Time PCR. While, in studies involving Asians, PCR-RFLP was the main genotyping technique. We proposed that the sensitivity and specificity of genotyping techniques are further explored to seek out optimal approaches that could minimize the genotyping errors. Therefore, this result should be carefully interpreted and confirmed by conducting a further analysis of additional published studies. Moreover, the population based subgroup analysis also revealed that the presence of the *MTHFR C677T* was related to a higher risk of glaucoma under heterozygote genetic model (TC vs. CC: OR = 1.350, 95% CI = 1.012-1.802, P = 0.041). Similarly, Huo et al. suggested that there were significant associations between *MTHFR C677T* polymorphism and POAG in allelic genetic model and additive genetic model for population-based subgroup, which indicated that the T allele or TT genotype might increase the risk of POAG \[**[@R34]**\].

Pathogenesis of POAG is a complex process. It is known that genetic factors play an important role in POAG susceptibility \[**[@R35]**\]. However, most of the molecular mechanisms leading to POAG development are still unknown \[**[@R36]**\]. It seems that approximately 5% of POAG is currently attributed to a single-gene or Mendelian forms of glaucoma. Gene mutations in various loci have been identified by genetic studies and a genetic basis for glaucoma pathogenesis has been established \[**[@R18]**,**[@R37]**\]. Although many epidemiological studies have been conducted to assess the roles of *MTHFR C677T* polymorphism and POAG risk in different populations, results have been inconclusive. Recently, in a case-control study of 144 POAG cases and 280 controls in Saudi Arabia, Al-Sharani et al. indicated that the allele T and genotype CT of *MTHFR C677T* polymorphism confer risk of POAG, while allele C and CC genotype had a different role \[**[@R30]**\]. However, four studies did not find an association between *MTHFR C677T* polymorphism and POAG risk in Iranian, Mexican, Indian and Greek populations \[**[@R25]**,**[@R27]**--**[@R29]**\]. In 2012, Xu et al. have conducted the first meta-analysis including ten studies with 1,406 cases and 1,216 controls on *MTHFR C677T* polymorphism \[**[@R38]**\]. They found no impact of *MTHFR C677T* polymorphism on POAG susceptibility in the pooled analysis. Since then, a series of better-designed case-control studies on the association between *MTHFR C677T* polymorphism and POAG were performed. In the current meta-analysis, 16 eligible studies with 2,179 cases and 2,069 controls were identified and analyzed. The present meta-analysis suggested that there was no significant association between *MTHFR C677T* and POAG risk in the overall comparisons. Consistent with our study, a previous meta-analysis was undergone in 2015, which included 13 studies with 1,970 POAG patients and 1,712 control subjects, suggesting that the *MTHFR C677T* was not associated with increased genetic susceptibility to POAG \[**[@R39]**\]. However, we found out they wrongly included one study evaluated about the *MTHFR C677T* polymorphism and PACG risk in their meta-analysis. Our literature search was more thorough, containing four more articles, which increased the total number of cases and controls, thus, providing a greater power to our conclusions. Moreover, we used one more genetic model, the allele genetic model, to gain a more comprehensive and accurate understanding of the *MTHFR C677T* polymorphism association.

Assessing heterogeneity in the meta-analysis of genetic associations is critical for model selection and interpretation of the results. On the other hand, heterogeneity and publication bias might influence the results of the meta-analysis. It is well known that different factors, such as population stratification, source of controls, population size, deviation from Hardy--Weinberg equilibrium, and other covariates could be the source of heterogeneity. In the current meta-analysis, moderate between-study heterogeneity was detected across studies under allele, heterozygote and dominant genetic models for *MTHFR C677T* polymorphism and thus we selected the random-effects model to summarize the ORs. Therefore, we performed a meta-regression analysis to find the source of between-study heterogeneity. The results showed that ethnicity, glaucoma types, genotyping methods, source of controls and HWE status did not contribute to substantial between-study heterogeneity in the current meta-analysis.

It was obvious that some limitations of this meta-analysis should be considered. First, the sample size reported in literature is still relatively small and might not provide sufficient power to estimate the association between the null *MTHFR A1298C* polymorphism and the glaucoma risk. Second, the language of the publications was limited to English. Third, the current meta-analysis was based predominantly on Asian and Caucasian research. No study from other parts of the world was found, such as the Africans. This suggested a partial result that is only relevant to the Asian and Caucasian subgroups. Forth, the existence of between-study heterogeneity in some comparisons might compromise the reliability of conclusion. Finally, glaucoma is a multifactorial disease that results from complex interactions between various genetic and environmental factors. Due to the unavailability of other detailed information, our results were based on single-factor estimates without adjustments for other risk factors. Further evaluation of glaucoma risk should pay more attention to the potential interactions among gene--gene, gene--environment, and even different polymorphism of the MTHFR gene and other loci. Despite these limitations, our meta-analysis had some clear advantages. Our meta-analysis contained the largest sample size to date to assess the association between the *MTHFR C677T* and *A1298C* polymorphisms and glaucoma risk.

In summary, the current meta-analysis indicated that *MTHFR C677T* might not be associated with the glaucoma risk, and yet the *MTHFR A1298C* polymorphism may be a risk factor for glaucoma. In the future, large sample studies should be warranted to investigate the association of *MTHFR C677T* and *A1298C* polymorphisms with glaucoma, and to examine the potential gene-gene and gene-environment interactions.
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